Skip to main content
. 2020 Mar 23;11:1517. doi: 10.1038/s41467-020-15328-3

Fig. 2. Sh2b1ΔLepR mice develop insulin resistance, glucose intolerance, and liver steatosis.

Fig. 2

a Overnight fasting blood glucose and insulin levels at 22 weeks of age. Male: LepR-Cre: n = 8 (insulin) and n = 9 (glucose), Sh2b1ΔLepR: n = 8; female: LepR-Cre: n = 5, Sh2b1ΔLepR: n = 6. b GTT and ITT at 20 weeks of age. Male: LepR-Cre: n = 9, Sh2b1ΔLepR: n = 8; female: f/f: n = 5, Sh2b1ΔLepR: n = 5. c Male mice (23 weeks) were stimulated with insulin. Liver and skeletal muscle extracts were immunoblotted with the indicated antibodies. Male: f/f: n = 6, Sh2b1ΔLepR: n = 6; female: f/f: n = 6, Sh2b1ΔLepR: n = 6. d Representative H&E staining of liver sections at 23 weeks of age (3 pairs). Scale bar: 200 μm. e Liver TAG levels (normalized to liver weight) at 23 weeks of age. Male: f/f: n = 5, Sh2b1ΔLepR: n = 4; female: f/f: n = 6, Sh2b1ΔLepR: n = 6. Data are presented as mean ± SEM. *p < 0.05, two-tailed unpaired Student’s t-test. Source data are provided as a Source Data file.